Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a post-translational modifying enzymes.
Alternative Bio's investors include HSG, XtalPi, F-Prime, Eight Roads Ventures.
Alternative Bio is headquartered in China, Japan.
Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a post-translational modifying enzymes.
Alternative Bio is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alternative Bio — Funding & Investors." VCBacked, February 10, 2025, https://www.vcbacked.co/company/alternative-bio. Accessed August 16, 2026.
VCBacked. (2025). Alternative Bio — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/alternative-bio
{{cite web |title=Alternative Bio — Funding & Investors |url=https://www.vcbacked.co/company/alternative-bio |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated